An improved medium for growing Staphylococcus aureus biofilm

Journal of Microbiological Methods

Volumn 90, Issue 2, 2012, Pages 115-118

  Chen, Ping ^a   Abercrombie, Johnathan J ^a   Jeffrey, Nicole R ^a   Leung, Kai P ^a  

^a US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

Biofilm; Human plasma; Microfluidic; Staphylococcus aureus

Indexed keywords

ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL VIABILITY; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BIOFILM; BRAIN HEART INFUSION; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; IN VITRO STUDY; MICROFLUIDICS; NONHUMAN; PLASMA; PRIORITY JOURNAL; REPRODUCIBILITY; SHEAR FLOW; STAPHYLOCOCCUS AUREUS; VALIDATION STUDY;

BACTERIOLOGICAL TECHNIQUES; BIOFILMS; CULTURE MEDIA; HUMANS; MICROBIAL VIABILITY; PLASMA; STAPHYLOCOCCUS AUREUS;

STAPHYLOCOCCUS AUREUS;

EID: 84861752094     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2012.04.009     Document Type: Article

References (14)

1. Archer N.K., Mazaitis M.J., Costerton J.W., Leid J.G., Powers M.E., Shirtliff M.E. Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence 2011, 2:445-459.
2. Beenken K.E., Blevins J.S., Smeltzer M.S. Mutation of sarA in Staphylococcus aureus limits biofilm formation. Infect. Immun. 2003, 71:4206-4211.
3. Ceri H., Olson M.E., Stremick C., Read R.R., Morck D., Buret A. The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J. Clin. Microbiol. 1999, 37:1771-1776.
4. Craigen B., Dashiff A., Kadouri D.E. The use of commercially available alpha-amylase compounds to inhibit and remove Staphylococcus aureus biofilms. Open Microbiol. J. 2011, 5:21-31.
5. Gotz F. Staphylococcus and biofilms. Mol. Microbiol. 2002, 43:1367-1378.
6. Gurjala A.N., Geringer M.R., Seth A.K., Hong S.J., Smeltzer M.S., Galiano R.D., Leung K.P., Mustoe T.A. Development of a novel, highly quantitative in vivo model for the study of biofilm-impaired cutaneous wound healing. Wound Repair Regen. 2011, 19:400-410.
7. Higashi J.M., Sullam P.M. Staphylococcus aureus biofilms. Biofilms, Infection, and Antimicrobial Therapy 2006, 81-108. Taylor & Francis, Boca Raton. J.L. Pace, M.E. Rupp, R.G. Finch (Eds.).
8. Houston P., Rowe S.E., Pozzi C., Waters E.M., O'Gara J.P. Essential role for the major autolysin in the fibronectin-binding protein-mediated Staphylococcus aureus biofilm phenotype. Infect. Immun. 2011, 79:1153-1165.
9. Jackson D.W., Suzuki K., Oakford L., Simecka J.W., Hart M.E., Romeo T. Biofilm formation and dispersal under the influence of the global regulator CsrA of Escherichia coli. J. Bacteriol. 2002, 184:290-301.
10. Luong T.T., Lei M.G., Lee C.Y. Staphylococcus aureus Rbf activates biofilm formation in vitro and promotes virulence in a murine foreign body infection model. Infect. Immun. 2009, 77:335-340.
11. Malachowa N., Whitney A.R., Kobayashi S.D., Sturdevant D.E., Kennedy A.D., Braughton K.R., Shabb D.W., Diep B.A., Chambers H.F., Otto M., et al. Global changes in Staphylococcus aureus gene expression in human blood. PLoS One 2011, 6:e18617.
12. Merino N., Toledo-Arana A., Vergara-Irigaray M., Valle J., Solano C., Calvo E., Lopez J.A., Foster T.J., Penades J.R., Lasa I. Protein A-mediated multicellular behavior in Staphylococcus aureus. J. Bacteriol. 2009, 191:832-843.
13. Shanks R.M., Donegan N.P., Graber M.L., Buckingham S.E., Zegans M.E., Cheung A.L., O'Toole G.A. Heparin stimulates Staphylococcus aureus biofilm formation. Infect. Immun. 2005, 73:4596-4606.
14. Shanks R.M., Meehl M.A., Brothers K.M., Martinez R.M., Donegan N.P., Graber M.L., Cheung A.L., O'Toole G.A. Genetic evidence for an alternative citrate-dependent biofilm formation pathway in Staphylococcus aureus that is dependent on fibronectin binding proteins and the GraRS two-component regulatory system. Infect. Immun. 2008, 76:2469-2477.